Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 10/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.69 |
| ▸ | HPGD | P15428 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.69 |
| ▸ | RECQL | P46063 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.69 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.69 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29838678 | 1.00 | FTO (0.69) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL20095 | 1.00 | FTO (0.69) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL29996062 | 1.00 | FTO (0.69) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL23158785 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL28092031 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| SCHEMBL27475520 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| Water SCHEMBL25247555 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| Ammonia Solution, Strong SCHEMBL29083296 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| Water SCHEMBL29653557 | 0.99 | FTO (0.67) | FTOMAPTHPGDMEN1HTT | |
| Oxalic Acid SCHEMBL27598167 | 0.97 | FTO (0.66) | FTOMAPTHPGDMEN1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3059 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260132218-A1 | FULLY HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN HER-2 | A & G PHARMACEUTICAL INC (US) | 2026-05-14 | — | — | US | claimed |
| EP-4735583-A1 | CELL SURFACE ENGINEERING OF TAILORED THERAPEUTIC GENE DELIVERY | The Children's Hospital of Philadelphia (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4695300-A2 | ANTIBODIES AND CONJUGATES AGAINST PROSTAGLANDIN F2 RECEPTOR INHIBITOR AND USES THEREOF | A & G Pharmaceutical, Inc. (US) | 2026-02-18 | — | — | EP | claimed |
| US-12492422-B2 | Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment | Sunbird Bio, Inc. (US) | 2025-12-09 | — | — | US | claimed |
| WO-2025242900-A1 | COACERVATE-FORMING REAGENTS AND METHODS | PARTITIONBIO LTD (GB) | 2025-11-27 | — | — | WO | claimed |
| US-20250361566-A1 | TUMOR-INFORMED DIGITAL PCR PROFILING TECHNOLOGY FOR MONITORING CIRCULATING TUMOR DNA | CHROMACODE INC (US) | 2025-11-27 | — | — | US | claimed |
| EP-4653448-A1 | COMPOUND FOR RNA CAPPING AND USE THEREOF | Guangzhou Henovcom Bioscience Co. Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| US-20250340957-A1 | Assays for the Detection of SARS-CoV2 Mutants | PROCOMCURE BIOTECH GMBH (AT) | 2025-11-06 | — | — | US | claimed |
| EP-4608872-A2 | SIZE-TUNABLE SYNTHETIC PARTICLES WITH TUNABLE OPTICAL PROPERTIES AND METHODS FOR USING THE SAME FOR IMMUNE CELL ACTIVATION | Slingshot Biosciences, Inc. (US) | 2025-09-03 | — | — | EP | claimed |
| EP-4590340-A1 | POLYMERS WITH STEROIDS OR VITAMINS | Sony Group Corporation (JP) | 2025-07-30 | — | — | EP | claimed |
| EP-3996815-A2 | HIV BINDING AGENTS | LAUSANNE UNIVERSITY HOSPITAL (CH) | 2022-05-18 | — | — | EP | claimed |
| US-20220128567-A1 | EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT | Sunbird Bio, Inc. | 2022-04-28 | — | — | US | claimed |
| US-20220128546-A1 | EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT | Sunbird Bio, Inc. | 2022-04-28 | — | — | US | claimed |
| WO-2022087224-A1 | METHOD OF TREATING FIBROSIS WITH A COMBINATION THERAPY | COHBAR, INC. (US) | 2022-04-28 | — | — | WO | claimed |
| CN-109219438-B | Bone removal of bisphosphonates | 加州大学董事会 | 2022-04-22 | — | — | CN | claimed |
| CN-114250320-A | RT-CPA primer group and kit for detecting porcine rotavirus | 甘肃省畜牧兽医研究所 | 2022-03-29 | — | — | CN | claimed |
| US-20220091120-A1 | METHOD FOR IDENTIFYING MODULATORS OF G3BP ACTIVITY | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | 2022-03-24 | — | — | US | claimed |
| CN-114214456-A | Method for differential diagnosis of EBV infected cell subtype and application thereof | 重庆医科大学附属儿童医院 | 2022-03-22 | — | — | CN | claimed |
| WO-2022056313-A2 | EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT | GLYMPSE BIO, INC. (US) | 2022-03-17 | — | — | WO | claimed |
| CN-114034529-A | Detection pretreatment method of anti-counterfeiting material containing trace fluorescent groups | 广东睿鹏材料科学有限公司 | 2022-02-11 | — | — | CN | claimed |